These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 36963837)

  • 1. Combined Oral Contraceptives As Victims of Drug Interactions.
    Li L; Yang X; Tran D; Seo SK; Lu Y
    Drug Metab Dispos; 2023 Jun; 51(6):718-732. PubMed ID: 36963837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial.
    Kangasniemi MH; Arffman RK; Joenväärä S; Haverinen A; Luiro K; Tohmola T; Renkonen R; Heikinheimo O; Tapanainen JS; Piltonen TT
    Hum Reprod; 2023 Jan; 38(1):89-102. PubMed ID: 36416543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis.
    Zimmerman Y; Eijkemans MJ; Coelingh Bennink HJ; Blankenstein MA; Fauser BC
    Hum Reprod Update; 2014; 20(1):76-105. PubMed ID: 24082040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 20 µg versus >20 µg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD003989. PubMed ID: 23904209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 20 µg versus >20 µg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
    Cochrane Database Syst Rev; 2011 Jan; (1):CD003989. PubMed ID: 21249657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20 microg versus >20 microg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
    Cochrane Database Syst Rev; 2008 Oct; (4):CD003989. PubMed ID: 18843653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003989. PubMed ID: 15846690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation.
    Bastianelli C; Farris M; Rosato E; Brosens I; Benagiano G
    Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1085-1098. PubMed ID: 30325245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptive agents.
    Shearman RP
    Med J Aust; 1986 Feb; 144(4):201-5. PubMed ID: 3945219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment.
    Stanczyk FZ; Archer DF; Bhavnani BR
    Contraception; 2013 Jun; 87(6):706-27. PubMed ID: 23375353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined oral contraceptive use and the risk of systemic lupus erythematosus.
    Bernier MO; Mikaeloff Y; Hudson M; Suissa S
    Arthritis Rheum; 2009 Apr; 61(4):476-81. PubMed ID: 19333988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined oral contraceptives: acceptability and effective use.
    Kubba A; Guillebaud J
    Br Med Bull; 1993 Jan; 49(1):140-57. PubMed ID: 8324604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined Hormonal Contraception - Which Pill for Which Patient?].
    Quaas P
    Praxis (Bern 1994); 2023; 112(4):205-210. PubMed ID: 36919319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen component of COCs: have we finally found a replacement for ethinyl estradiol?
    Voedisch AJ; Fok WK
    Curr Opin Obstet Gynecol; 2021 Dec; 33(6):433-439. PubMed ID: 34747879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
    Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
    Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral combined contraception: is there any difference between ethinyl-estradiol and estradiol?].
    Trémollieres F
    Gynecol Obstet Fertil; 2012 Feb; 40(2):109-15. PubMed ID: 22244780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring combination oral contraceptives to the individual woman.
    Archer DF; Lasa IL
    J Womens Health (Larchmt); 2011 Jun; 20(6):879-91. PubMed ID: 21631372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.